Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb Read more
Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines Read more
Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program Read more
CytoDyn to Submit Newly Completed Topline Report of CD12 Trial Results to Regulatory Agencies in Multiple Countries including India and Philippines Read more
Prestige BioPharma Enters MOU with Busan City for Establishment of its R&D Centre in Busan, South Korea Read more
BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity Read more